Alan B. Cantor focuses on Cancer research, Internal medicine, Surgery, Cancer and Genetics. His Cancer research research integrates issues from Epidermal growth factor receptor, Lung cancer, Loss of heterozygosity, Tumor suppressor gene and STAT3. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
Alan B. Cantor combines subjects such as Relative risk and Sentinel lymph node, Breast cancer with his study of Surgery. His work in the fields of Ovarian cancer overlaps with other areas such as Geriatrics. His study in Transcription factor is interdisciplinary in nature, drawing from both Transcription, Regulation of gene expression and Haematopoiesis.
His primary areas of investigation include Internal medicine, Surgery, Oncology, Cancer research and Pathology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology. The concepts of his Surgery study are interwoven with issues in Sentinel lymph node, Breast cancer and Metastasis.
His Oncology research incorporates elements of Survival rate, Gemcitabine and Prostate cancer. He focuses mostly in the field of Cancer research, narrowing it down to topics relating to Lung cancer and, in certain cases, Respiratory disease. Many of his studies on Pathology apply to Tumor progression as well.
Alan B. Cantor mainly focuses on Transcription factor, Cell biology, RUNX1, Cancer research and Biochemistry. Genetics and Gene are inextricably linked to his Transcription factor research. As a part of the same scientific study, he usually deals with the Genetics, concentrating on Genome-wide association study and frequently concerns with Phenotype.
His research in Cell biology intersects with topics in Chromatin, Chromatin immunoprecipitation, Erythropoietin and Zinc finger. His studies in Cancer research integrate themes in fields like Platelet disorder, Downregulation and upregulation, Ribosome biogenesis and Stem cell, BMI1. His work on Amino acid, mTORC1, Leucine and Cell type as part of general Biochemistry research is frequently linked to Amino acid transporter, thereby connecting diverse disciplines of science.
The scientist’s investigation covers issues in Biochemistry, Internal medicine, Intervention, Oncology and Neurofibromatosis. Alan B. Cantor combines topics linked to Magnetic resonance imaging with his work on Internal medicine. He interconnects Surgery, Sirolimus, Gastroenterology, Toxicity and Neurofibromatoses in the investigation of issues within Magnetic resonance imaging.
His work carried out in the field of Intervention brings together such families of science as Psychological intervention, Adverse effect, Quality of life, Physical therapy and Anthropometry. His research in Psychological intervention focuses on subjects like Risk factor, which are connected to Cancer. His Oncology research is multidisciplinary, relying on both Clinical endpoint, PI3K/AKT/mTOR pathway, Combination therapy and Malignant peripheral nerve sheath tumor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
John J. Albertini;Gary H. Lyman;Charles Cox;Tim Yeatman.
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
Akira Nakagawara;Miwako Arima-Nakagawara;Nancy J. Scavarda;Christopher G. Azar.
The New England Journal of Medicine (1993)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran;Tobias F. Menne;Jian Xu;Thomas E. Akie.
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
Tuya Pal;Jenny Permuth-Wey;A R N Judith Betts;Jeffrey P. Krischer.
Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Michelle A. Blaskovich;Jiazhi Sun;Alan Cantor;James Turkson.
Cancer Research (2003)
Transcriptional regulation of erythropoiesis: an affair involving multiple partners.
Alan B Cantor;Stuart H Orkin;Stuart H Orkin.
Constitutive Activation of Stat3 in Human Prostate Tumors and Cell Lines Direct Inhibition of Stat3 Signaling Induces Apoptosis of Prostate Cancer Cells
Linda B Mora;Ralf Buettner;John Seigne;Jose Diaz.
Cancer Research (2002)
A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
Jonghwan Kim;Andrew J. Woo;Jianlin Chu;Jonathan W. Snow.
Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo
Channing Yu;Alan B. Cantor;Haidi Yang;Carol Browne.
Journal of Experimental Medicine (2002)
The uncertainty principle and industry-sponsored research
Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields.
The Lancet (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: